Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Samuel Raj

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Nanobiotechnology|May 6, 2023
Therapeutic applications of nanobiotechnologyYogesh Dutt, Ramendra Pati Pandey, Mamta Dutt, et al.
Frontiers in Microbiology|March 5, 2025
Unveiling roles of beneficial gut bacteria and optimal diets for healthSuresh Kumar, Riya Mukherjee, Pratibha Gaur, et al.
Biomolecules|August 26, 2023
Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the NanoscaleHimanshu, Riya Mukherjee, Jasmina Vidic, et al.
Discover Nano|September 7, 2024
Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatmentRuby Dhiman, Nancy Bazad, Riya Mukherjee, et al.
ADMET & DMPK|March 19, 2026
Insights into drug resistance in <i>Leishmania</i>: Mechanisms, therapeutics, and clinical case studiesGajala Deethamvali Ghousepeer, Mansi Rani, Aman Kumar, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2010
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in IndiaAlka Khanna, V Samuel Raj, Bansidhar Tarai, et al.
Emerging Infectious Diseases|February 9, 2008
Ciprofloxacin-resistant Neisseria meningitidis, Delhi, IndiaSmita Singhal, Kedar P Purnapatre, Vandana Kalia, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficileTarun Mathur, Manoj Kumar, Tarani K Barman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 11, 2018
In vivo efficacy and pharmacokinetics of bi-aryl oxazolidinone RBx 11760 loaded polylactic acid-polyethylene glycol nanoparticles in mouse hematogenous bronchopneumonia and rat groin abscess caused by Staphylococcus aureusTarani Kanta Barman, Manoj Kumar, Tridib Chaira, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 27, 2026
Potential efficacy of repurposed drugs for treating drug-resistant visceral leishmaniasisGajala Deethamvali Ghousepeer, Shubhankar Kumar Singh, Shailja Singh, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Nanobiotechnology|May 6, 2023
Therapeutic applications of nanobiotechnologyYogesh Dutt, Ramendra Pati Pandey, Mamta Dutt, et al.
Frontiers in Microbiology|March 5, 2025
Unveiling roles of beneficial gut bacteria and optimal diets for healthSuresh Kumar, Riya Mukherjee, Pratibha Gaur, et al.
Biomolecules|August 26, 2023
Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the NanoscaleHimanshu, Riya Mukherjee, Jasmina Vidic, et al.
Discover Nano|September 7, 2024
Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatmentRuby Dhiman, Nancy Bazad, Riya Mukherjee, et al.
ADMET & DMPK|March 19, 2026
Insights into drug resistance in <i>Leishmania</i>: Mechanisms, therapeutics, and clinical case studiesGajala Deethamvali Ghousepeer, Mansi Rani, Aman Kumar, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2010
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in IndiaAlka Khanna, V Samuel Raj, Bansidhar Tarai, et al.
Emerging Infectious Diseases|February 9, 2008
Ciprofloxacin-resistant Neisseria meningitidis, Delhi, IndiaSmita Singhal, Kedar P Purnapatre, Vandana Kalia, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficileTarun Mathur, Manoj Kumar, Tarani K Barman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 11, 2018
In vivo efficacy and pharmacokinetics of bi-aryl oxazolidinone RBx 11760 loaded polylactic acid-polyethylene glycol nanoparticles in mouse hematogenous bronchopneumonia and rat groin abscess caused by Staphylococcus aureusTarani Kanta Barman, Manoj Kumar, Tridib Chaira, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 27, 2026
Potential efficacy of repurposed drugs for treating drug-resistant visceral leishmaniasisGajala Deethamvali Ghousepeer, Shubhankar Kumar Singh, Shailja Singh, et al.
Pageof 6